TBBPA targets converging key events of human oligodendrocyte development resulting in two novel AOPs

Main Article Content

Jördis Klose
Julia Tigges
Stefan Masjosthusmann
Katharina Schmuck
Farina Bendt
Ulrike Hübenthal
Patrick Petzsch
Karl Köhrer
Katharina Koch
Ellen Fritsche

Abstract

Myelinating oligodendrocytes (OLs) establish saltatory nerve conduction during white matter development. Thus, interference with oligodendrogenesis leads to an adverse outcome on brain performance in the child due to aberrant myelination. An intertwined network of hormonal, transcriptional and biosynthetic processes regulates OLs development, thereby simultaneously creating various routes of interference for environmental toxicants. The flame retardant tetrabromobisphenol A (TBBPA) is debated as an endocrine disruptor, especially of the thyroid hormone (TH) system. We identified two independent modes-of-action (MoA) how TBBPA interferes with the establishment of a population of maturing OLs, dependent and independent of TH signaling. Combining the previously published oligodendrocyte maturation assay (NPC6) with large-scale transcriptomics, we describe TBBPA as a TH disruptor impairing human OL maturation in vitro by dysregulation of oligodendrogenesis-associated genes (i.e. MBP, KLF9 and EGR1). Furthermore, TBBPA disrupts a gene expression network regulating cholesterol homeostasis, reducing OL numbers independently of TH signaling. These two MoA converge in a novel putative Adverse Outcome Pathway (AOP) network on the key event (KE) hypomyelination. Comparative analyses of human and rat neural progenitor cells (NPCs) revealed that human oligodendrogenesis is more sensitive to endocrine disruption by TBBPA. Therefore, we emphasize that ethical, cost-efficient and species-overarching in vitro assays are needed for DNT hazard assessment. By incorporation of large-scale transcriptomic analyses, we brought the NPC6 assay to a higher readiness level for future applications in a regulatory context. The combination of phenotypic and transcriptomic analyses helps to study MoA to eventually build AOPs for a better understanding of neurodevelopmental toxicity.

Article Details

How to Cite
Klose, J., Tigges, J., Masjosthusmann, S., Schmuck, K., Bendt, F., Hübenthal, U., Petzsch, P., Köhrer, K., Koch, K. and Fritsche, E. (2020) “TBBPA targets converging key events of human oligodendrocyte development resulting in two novel AOPs”, ALTEX - Alternatives to animal experimentation, 00. doi: 10.14573/altex.2007201.
Section
Articles

Most read articles by the same author(s)